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Defective Epstein-Barr virus (EBV) has a deleted and rearranged genome (termed het DNA) that disrupts
latency and induces standard EBV to replicate in vitro. We used the polymerase chain reaction to detect, in 2
of 10 patient samples, the junction of abnormally juxtaposed EBV DNA fragments BamHI W and Z, a genomic
rearrangement responsible for the biologic activity of het DNA. By sequence analysis, the junction in wild-type
defective DNA appears to be similar but not identical to the recombination in the DNA of laboratory strain
P3HR-1. The presence of this marker for het DNA in the epithelial lesions of two patients suggests a role for
defective EBV in a human pathologic process.
Epstein-Barr virus (EBV) is a human herpesvirus that
establishes a persistent, replicative infection at oropharyn-
geal and genital sites (25, 26). The permissiveness of mucosal
surfaces for EBV replication contrasts with the stringently
latent life cycle of the virus in circulating B lymphocytes.
Although differences in EBV activity have been attributed to
variables of host cell regulation, an in vitro replicative
system has been shown to contain defective EBV whose
deleted, rearranged genome has the capacity to induce
replication of latent EBV (4, 6, 10, 12, 14, 18, 21, 27).
Defective EBV was first identified in a cellular subclone of
P3HR-1, a Burkitt's lymphoma-derived cell line (11, 21). The
deleted and rearranged genome (het DNA) in defective virus
forms self-contained replicons which multiply independently
of standard EBV DNA and are capable of cell-to-cell spread
(17). The ability to induce replication maps to a 2.7-kilobase-
pair WZhet fragment, which is formed by nonhomologous
recombination between DNA sequences in BamHI Z and W
fragments separated in the standard genome by more than 55
kilobase pairs (Fig. 1) (5, 8). The WZhet recombinant retains
the entire open reading frame of standard BamHI-Z, termed
BZLF1 (13), encoding a product that trans activates the lytic
origin of EBV DNA replication (3, 9, 28). The capability of
het DNA to activate EBV replication results from up-
regulation of BZLF1 by positive regulatory elements newly
positioned on either side of the gene (22).
To determine if defective EBV exists in vivo, we used
polymerase chain reaction (PCR) amplification to examine
DNA from the epithelial lesion oral hairy leukoplakia, which
is found predominantly in patients with acquired immunode-
ficiency syndrome and is known to contain abundant repli-
cative EBV (7; L. Resnick, J. Herbst, and N. Raab-Traub, J.
Am. Acad. Dermatol., in press). To test for rearranged EBV
DNA, we synthesized oligonucleotide primers framing a
181-base-long sequence spanning the abnormal junction in
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the WZhet fragment (Fig. 1). Two 32P-labeled 30-base oligo-
nucleotides specific for sequences in either the BamHI-Z or
-W portion of WZhet DNA were used to detect the PCR
product on Southern blots. Oligonucleotides were made with
a model 380A DNA synthesizer (Applied Biosystems) using
phosphoramidite chemistry. Probes were [y-32P]ATP end
labeled (ICN Radiochemicals) with cloned T4 polynucleo-
tide kinase (U.S. Biochemicals Corp.) (16). Control DNAs
were HR-1 cellular clones 5 (het+) and 16 (het-) (21) as well
as cytomegalovirus, varicella-zoster virus, and human DNA.
Test samples consisted of total cellular DNA extracted from
the hairy leukoplakia lesions of 10 patients with acquired
immunodeficiency syndrome. All samples were positive for
EBV DNA by standard Southern blot hybridization. Analy-
sis of the EBV termini identified abundant arrays of terminal
fragments representing linear viral DNA of a highly lytic
infection (19). In addition to the standard BamHI-Z, a
1.3-kilobase-pair fragment homologous to BamHI-Z was
detected at very low levels in the DNA from 1 of the 10
patient samples, suggesting the presence of a rearranged
EBV genome (data not shown).
PCR amplification of 1 ,ug of total cellular DNA extracted
from biopsies of hairy leukoplakia was performed with
Thermus aquaticus (Taq) DNA polymerase in a reaction
mixture of 100 ,ul as described in detail elsewhere (15).
Samples were boiled for 10 min; heating cycles of 2 min at
45°C, 2 min at 63°C, and 1 min at 90°C were performed 30
times on a DNA Thermal Cycler (Perkin Elmer Cetus
Corp.). PCR product (18 jxl per well) was electrophoresed on
a 3% NuSieve-1% SeaKem agarose gel (FMC Corp.) and
transferred to a Nytran membrane (Schleicher & Schuell,
Inc.). Blots were prehybridized at 51°C for 3 h in 6x SSC
(lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.2%
sodium dodecyl sulfate-5 x Denhardt solution with 0.5 mg of
denatured calf thymus DNA per ml. Hybridization was
performed overnight at 51°C in hybridization fluid containing
32P-labeled probes (106 cpm/ml).
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FIG. 1. Organization of the central palindrome of heterogeneous EBV DNA present in HR-1 cellular clone 5 and relation of synthetic
oligonucleotides to the 181-base sequence targeted for PCR amplification (restriction endonuclease maps adapted from Rabson et al. [20] and
Jenson et al. [12]). Symbol: II, junction ofDNA fragments that are not contiguous in the standard HR-1 genome but are abnormally juxtaposed
in heterogeneous DNA. Primer sequences used to amplify the WZhet junction were 5' AATAGACAGCCCAGTTGAAA 3' (Z specific) and
5' GTCCAGCGCGTTTACGTAAG 3' (W specific). Oligonucleotide probes used for detection of the PCR amplification products were 5'
CATGCAGCAGACATTCATCATTTAGAAATG 3' (Z probe) and 5' AGTGGTCCCCCTCCCTAGAACTGACAATTG 3' (W probe). kbp,
Kilobase pairs.
After DNA amplification, 2 of 10 patient samples (includ-
ing the one with an anomalous BamHI-Z signal on standard
Southern blot) had a PCR product that hybridized to both the
BamHI-Z- and BamHI-W-specific oligonucleotide probes,
indicating a genomic rearrangement (Fig. 2, lanes 2 and 9).
No product could be detected in the remaining eight patient
samples or in the negative controls containing irrelevant and
het- DNA. Amplification of het+ HR-1 cellular clone 5
yielded two bands 181 and 120 bases in length.




FIG. 2. Rearranged (WZhet) EBV DNA from oral hairy leuko-
plakia lesions of patients with acquired immunodeficiency syn-
drome. Southern blot analysis of the PCR products from patient
lesions (lanes 1 through 10), positive control HR-1 cellular clone 5
(het+) (lane 11), and negative control HR-1 cellular clone 16 (het-)
(lane 12) demonstrated WZhet DNA in patient samples 2 and 9 when
both the Z-specific (above) and W-specific (not shown) probes were
used for hybridization. The doublet band in lane 11 represents
abnormal product migration due to secondary structure (see text).
The molecular weight marker (HaeIII digestion of XX174 replica-
tive-form DNA) is in base pairs.
To determine the basis of this size variability, we cloned
PCR products from the het+ control and clinical sample 9
(Fig. 2, lanes 11 and 9, respectively). Primers, phosphory-
lated at their 5' ends, were used in the PCRs from which
DNA for cloning was obtained. Phosphorylated PCR prod-
ucts were blunt end ligated into dephosphorylated PvuII-
restricted pATX, and the ligation products were used to
transform competent MC1061 cells (16, 23). Positive clones
were identified by Benton-Davis screening with the Z-spe-
cific probe (2). Recombinant DNA was sequenced by the
dideoxy-chain termination method with Sequenase (U.S.
Biochemicals) and oligonucleotide primers complementary
to pATX vector sites (24). On sequence analysis, the cloned
PCR product from the clinical sample was 160 bases in
length (Fig. 3). Moreover, the point of recombination be-
tween BamHI-W and BamHI-Z in the patient het DNA was
shifted in relation to the prototype het DNA (13), so that an
additional 45 bases of BamHI-W were included. Recombi-
nation occurred at a single adenosine residue shared by both
fragments. This alteration led to the preservation within the
wild-type recombinant of the eucaryotic promotor sequence
TATAAA contained in BamHI-W but interrupted by recom-
bination of BamHI W and Z fragments in laboratory defec-
tive virus (13).
Sequences of all het+ clones agreed with the published
sequence of the targeted 181-base segment (Fig. 3, top
sequence). When the PCR product was subjected to electro-
phoresis on a denaturing polyacrylamide gel, the doublet
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FIG. 3. Altered WZhet junction of defective EBV DNA in hairy leukoplakia lesions. The top line is the sequence from 15 clones of PCR
product obtained with the HR-1 clone 5 (het+) control and is identical to the predicted 181-base published sequence (13). The bottom sequence
is a 160-base variant from clinical sample 9. Numerical designations are sequence coordinates of the 2.7-kilobase-pair WZhet DNA per Jenson
et al. (13). Stippled areas, BamHI-Z; unstippled areas, BamHI-W; boxed residues, bases shared by both fragments that form the
recombination site; lowercase letters, additional 45 bases of standard BamHI-W; underlining, putative promotor sequence TATAAA;
boldface type, region of PCR primers. Base 1618 in the patient sample differs from that in het DNA but concurs with the BamHI-W sequence
of EBV prototypes B95-8 and HR-1 (12).
seen on the agarose gel (Fig. 2) resolved into a single
181-base band, indicating that secondary structure was the
cause of this aberrant migration pattern (data not shown).
Ready detection of the W-Z rearrangement by PCR but
not by standard blot hybridization techniques suggests that a
minimal number of defective virions may be generated.
Although defective EBV replicates preferentially to standard
virus in tissue culture (17), this advantage may not hold for
heterogeneous cell populations in vivo. However, a low
copy number does not lessen the potential biologic signifi-
cance of the defective virus. In contrast to defective inter-
fering particles that inhibit replication by appropriating the
viral replicative machinery, the het DNA of defective EBV
appears to enhance replication by trans activation of the
lytic origin of DNA replication, a mechanism that conceiv-
ably would operate if only a single copy of the defective
genome were present.
The apparent absence of het DNA in eight clinical samples
could be interpreted as evidence that the defective DNA is
not causal but rather the occasional by-product of active
virus replication. However, in experimental systems with
other viruses, in which the introduction of defective virus
clearly altered the disease course, isolation of defective
interfering particles has proven difficult (1). In our study, the
variability in the W-Z junction of wild-type het DNA may
further complicate detection of this molecular alteration by
PCR when the point of recombination occurs outside the
region demarcated by a particular primer set (Fig. 3). Alter-
natively, single base substitutions in the regions of het DNA
recognized by the PCR primers may interfere with primer
annealing.
The presence of rearranged genomic EBV DNA in a lesion
noted for its abundant replicative virus may represent a
novel strategy by which persistent viruses move, by way of
recombinational events, from a latent to a replicative stage in
their life cycle. Because the ability of viruses to generate
defective particles in vitro often depends on the cell type
infected (1), the detection of defective EBV molecules in
hairy leukoplakia lesions suggests that epithelial cells may be
critical for EBV recombinational events. The enhanced
susceptibility of the epithelium to this mode of viral patho-
genesis may underlie the divergent biology of EBV at
lymphoid and epithelial sites.
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